Benefits of Urolithin A

Evidence-Based Benefits

• Mitophagy induction — Urolithin A stimulates the clearance of damaged mitochondria via the PINK1/Parkin-mediated mitophagy pathway, potentially improving mitochondrial quality control.
• Muscle function preservation — a small-scale RCT in older adults (n=20) demonstrated that 1000mg daily for 30 days improved muscle endurance and strength, specifically in tasks like the 6-minute walk test.
• Skeletal muscle endurance — preliminary human data suggests Urolithin A may enhance aerobic capacity and muscular endurance by optimizing mitochondrial oxidative capacity, though long-term effects in athletic populations require more large-scale RCTs.
• Cellular longevity markers — animal models (C. elegans and Drosophila) show significant increases in lifespan and healthspan, likely through the reduction of mitochondrial-derived reactive oxygen species (ROS).
• Metabolic health support — emerging evidence suggests Urolithin A may improve insulin sensitivity and glucose metabolism by enhancing mitochondrial efficiency, though most current human data is limited to small cohorts and short durations.

What the Research Says

The research landscape for Urolithin A is characterized by a transition from robust mechanistic evidence in cell cultures to emerging, though limited, human clinical data. While animal models and in vitro studies provide strong evidence for its role in stimulating mitophagy—the lysosomal degradation of damaged mitochondria—human-centric evidence is currently restricted to a small number of pilot RCTs. A notable 2022 study involving 30 participants demonstrated that daily supplementation with 1g of Urolithin A over 30 days may improve muscle function and reduce muscle damage markers, but the small sample size prevents broad generalization. Further large-scale, long-term human RCTs are required to confirm its efficacy for sarcopenia prevention and metabolic health.